Medical news & information, drug approvals & FDA & NIH medical research news. Information on prescribing drugs, patient education, infectious diseases, the pharmaceutical industry & biomedical news.



Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 2 Published - 14:00 UTC    08:00 EST    27-March-2001      
Issue 86 Next Update - 14:00 UTC 08:00 EST    28-March-2001      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya



















Proceed To Article In Today's Vidyya
medical bag
The leading cause of potentially fatal events in millions of people with type 2 diabetes can be reduced by the well established medication, Lipidil ® (fenofibrate).


Proceed To Article Fenofibrate Significantly Reduces Risk Of Atherosclerosis
An international study published Friday, 23 March 2001 in The Lancet shows that a well established drug -- fenofibrate -- significantly reduces the risk of atherosclerosis -- the leading cause of potentially fatal events in millions of people with type 2 diabetes. More...

Proceed To Article Measles Toll Reaches Six In Ugandan Capital: Plague Reported In Zambia
Six children have died of measles and 15 others are in critical condition after an outbreak of measles in Ugandan capital Kampala. Elsewhere, the World Health Organization has received preliminary reports of 23 hospitalized cases of plague, including 3 deaths in Petauke district of Zambia. More...

Proceed To Article NIDDK Team Uncovers A Novel Pathway That Controls Eating
NIDDK scientists and their collaborators have discovered that a protein called M3 muscarinic acetylcholine receptor helps regulate how much animals eat. The findings, which appear in the 8 March 2001, issue of Nature, highlight just how complex the brain chemistry governing food intake is. More...

Proceed To Article Prescribing Information: Fenofibrate (Lipidil ®)
Fenofibrate lowers elevated serum lipids by decreasing the low density lipoprotein (LDL) fraction rich in cholesterol and the very low density lipoprotein (VLDL) fraction rich in triglycerides. In addition, fenofibrate increases the high density lipoprotein (HDL) cholesterol fraction. Fenofibrate appears to have a greater depressant effect on the very low density lipoproteins (VLDL) than on the low density lipoproteins (LDL). Therapeutic doses of fenofibrate produce variable elevations of HDL cholesterol, a reduction in the content of the total low density lipoproteins cholesterol, and a substantial reduction in the triglyceride content of very low density lipoproteins.
More...


Proceed To Article

BSE: Background, Current Concerns, And US Response
The United States has aggressive BSE surveillance and prevention programs in place. FDA's restrictions on certain animal feed ingredients and its import alerts on cattle products are a critical part of this program. In addition, USDA has an import ban on certain cattle and cattle products, and CDC has established surveillance and investigation programs for suspected human TSE cases. USDA's Animal and Plant Health Inspection Service (APHIS) introduced import restrictions in 1989, when it banned the import of all live ruminants (cud-chewing animals, such as cows, sheep, and goats) from the UK.
More...


Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.

Medical news & information, drug approvals & FDA & NIH medical research news. Information on prescribing drugs, patient education, infectious diseases, the pharmaceutical industry & biomedical news.